Skip to main content
Labocanna Spolka Akcyjna logo

Labocanna Spolka Akcyjna — Investor Relations & Filings

Ticker · LCN ISIN · PLCCTLS00017 LEI · 259400GAPNZTGIR9PK55 WAR Manufacturing
Open in API
Filings indexed 135 across all filing types
Latest filing 2025-12-22 M&A Activity
Country PL Poland
Listing WAR LCN

About Labocanna Spolka Akcyjna

http://www.labocanna.pl

Labocanna Spolka Akcyjna is a company engaged in the cultivation, production, and distribution of hemp products. Its offerings include food and medical hemp-derived items. The company's primary strategic goal is to launch the production of medical marijuana for patients and clinical use, with a focus on indoor cultivation methods. Labocanna is pursuing collaborations with research institutes to produce pharmaceutical raw materials and is actively developing new compounds and mixtures based on cannabinoids such as CBD, CBG, and CBC. The company plans to manage 500 hectares of cultivation fields through acquisitions and contracting.

Recent filings

Filing Released Lang Actions
Sprzedaż akcji w Vinci Gen S.A. - Content (PL)
M&A Activity Classification · 95% confidence The document is a short announcement from Labocanna S.A. regarding the sale of all shares held in another company (Vinci Gen S.A.). It describes a specific corporate transaction involving the disposal of assets and loss of control over a subsidiary. Since it does not fit into specific categories like M&A (which usually implies a merger or takeover bid) or share buybacks, and it is a formal regulatory disclosure of a material event, it falls under the general regulatory filing category.
2025-12-22 Polish
Zawarcie przedwstępnej umowy na import marihuany medycznej - Content (PL)
Regulatory Filings Classification · 100% confidence The document is a formal announcement by Labocanna S.A. regarding a signed preliminary cooperation agreement for the import and distribution of medical marijuana in Poland, involving a German entity. It details the obligations of both parties (registration with URPL, ordering 500 kg, distribution) and states that the announcement is being published because the agreement may significantly impact future financial results and aligns with the company's strategy. This type of announcement, detailing a significant business development or contract that impacts future performance but is not a standard periodic financial report (like 10-K or IR), typically falls under general regulatory disclosures. Since it describes a significant business transaction/contract, it is best classified as a general Regulatory Filing (RNS), as there is no specific category for 'Material Contract Announcement' and it doesn't fit the definitions for financing (CAP), M&A (TAR), or insider trading (DIRS). Given the context of Polish regulatory filings, RNS serves as the appropriate catch-all for material, non-standard disclosures.
2024-02-09 Polish
Rozwiązanie Umowy Inwestycyjnej w sprawie połączenia ze spółką Foxbuy.com S.A. - Content (PL)
M&A Activity Classification · 95% confidence The document text is very short (681 characters) and describes the termination of an Investment Agreement ('Umowę Inwestycyjną') between two Polish companies, Labocanna S.A. and Foxbuy.com S.A., which involved a planned merger/takeover. This action relates to a significant corporate transaction, specifically the termination of a merger proposal. Based on the definitions, the closest fit for announcing the termination of a merger proposal or takeover bid is 'M&A Activity' (TAR). It is not a standard financial report, earnings release, or management change announcement. Since it directly concerns the cessation of a transaction that would fall under TAR, TAR is the most appropriate classification.
2024-02-09 Polish
Lista akcjonariuszy, którzy wzięli udział w Walnym Zgromadzeniu oraz mieli co najmniej 5% głosów - Content (PL)
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document text, written in Polish, details the list of shareholders who held at least 5% of the votes at an Extraordinary General Meeting (Nadzwyczajne Walne Zgromadzenie - NWZA) held on January 24, 2024. It explicitly lists the names, number of shares, and corresponding voting percentages for major shareholders (Paweł Kiciński and Cezary Jasiński) present at the meeting. This content directly relates to the official results of a shareholder vote at a general meeting. Therefore, the most appropriate classification is Declaration of Voting Results & Voting Rights Announcements (DVA). The document is short and contains the results directly, not just an announcement of results.
2024-01-24 Polish
Otrzymanie pisma z Instytutu Weterynaryjnego - Państwowego Instytutu Badawczego w Puławach - Content (PL)
Regulatory Filings Classification · 95% confidence The document text is a short announcement from the Management Board ('Zarząd') of Labocanna S.A. It references a previous report and details a specific business development: receiving a letter stating the impossibility of concluding a cooperation agreement with the National Veterinary Institute regarding medical marijuana cultivation due to high costs and legislative uncertainty. This is a specific operational update concerning a potential partnership or business direction. It is not a full financial report (10-K, IR), an earnings release (ER), a management discussion (MDA), or a director's dealing (DIRS). Given its nature as a specific, material business event update that doesn't fit the other specific categories (like M&A, Capital Change, or Legal), it best fits the general 'Regulatory Filings' (RNS) category as a miscellaneous material event disclosure, or potentially a general business update not covered elsewhere. Since it is a specific communication about a failed negotiation/partnership, and not a standard financial report announcement, RNS is the most appropriate fallback.
2024-01-18 Polish
Wygaśnięcie umowy o zachowaniu poufności - Content (PL)
Regulatory Filings Classification · 98% confidence The document is a short announcement (544 characters) from the Management Board ('Zarząd') of Labocanna S.A. It references previous ESPI reports and states that a Non-Disclosure Agreement (NDA) expired on December 31, 2023, and that further commercial cooperation negotiations will not be pursued. This is a specific update regarding business negotiations/status, not a full financial report (10-K, IR), an earnings release (ER), or a management discussion (MDA). Since it is a specific business update that doesn't fit the other precise categories (like DIRS, DIV, CAP), it falls best under the general 'Regulatory Filings' (RNS) category as a miscellaneous regulatory disclosure regarding business status, or potentially a very specific type of Management Report (MDA) if the scope was broader, but given the brevity and nature, RNS is the most appropriate fallback for a specific, non-standard business event disclosure.
2024-01-02 Polish

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.